Live
Core Diagnostics has got USD 12 million (around Rs 82 crore) funding from various investors that includes US based F-Prime Capital Partners.
It has said in a statement that Eight Roads Ventures, US based F-Prime Capital Partners and existing investor Artiman Ventures will invest USD 12 million in the company.
The terms of the transaction have not been disclosed.
According to it, the investment will be used by the company for introducing multiple new advanced tests for oncology as well as for other segments such as infectious diseases and gynaecology.
